M

Machinify

AI-driven healthcare operations optimization platform

Assistant General Counsel - Multiple Teams

Contract
$225k - $250k+ Annual Bonus
Expert
JD
Remote in USA
Remote
LegalLegal Counsel & Legal Support

About the job

Requirements
  • A JD from an accredited law school and active membership in good standing in at least one U.S. state bar.
  • At least 8 years of commercial contracting experience at a law firm, in-house, or both, including substantial in-house experience.
  • Demonstrated ownership of AI and data rights provisions in commercial agreements, including training rights, model and output ownership, and data use limitations.
  • Working command of HIPAA and health data privacy, including business associate agreements, de-identification standards, and protected health information handling in a vendor or business associate posture.
  • Substantive intellectual property experience in a software or data context, including licensing, ownership structuring, and open source.
  • Healthcare industry experience in payer, payment integrity, health technology, provider, or a closely related setting.
  • A track record working directly with Sales or Client Success, including client-facing negotiation and explaining legal positions to non-lawyers.
  • Ability to operate within privacy and compliance standards set by the Chief Privacy Officer and escalate when a deal exceeds those standards.
  • Judgment to advise a fast-moving business on unsettled questions without blocking a deal or approving it without due consideration.
Responsibilities
  • Own AI provisions in customer, partner, and vendor agreements, including training and improvement rights, de-identification and aggregation, model and output ownership, human oversight, performance and accuracy commitments, transparency and explainability obligations, and allocation of AI-specific risk.
  • Draft and maintain standard AI contract language and fallback positions, clarifying what is standard, negotiable, or requires escalation.
  • Negotiate data use and data rights terms with health plan customers, including secondary use, derived data, retention and deletion, and downstream restrictions.
  • Advise product and engineering teams on new AI features before launch, including contract permissions, required contract terms, and legal constraints arising from design choices.
  • Track AI regulation and health-sector AI guidance and translate it into contract language and product guidance.
  • Convert positions set by the Chief Privacy Officer, Compliance, and Information Security into contract language, standard clauses, and defined fallback positions.
  • Negotiate business associate agreements, data processing agreements, data protection schedules, and security exhibits, resolving conflicts between customer paper and platform architecture.
  • Recognize when customer requests concerning HIPAA, state health privacy and consumer privacy requirements, offshore access, and subcontractor restrictions exceed approved positions, and escalate those requests to the Chief Privacy Officer and Compliance with a clear explanation.
  • Report recurring negotiation issues to the relevant teams so standards can be revised.
  • Structure intellectual property ownership, license scope, and feedback and improvement provisions to preserve platform-level intellectual property while meeting customer needs.
  • Handle open source and third-party model and data licensing questions raised by engineering, and flag license choices that constrain commercial positions.
  • Support intellectual property protection strategy, including invention capture, trade secret hygiene, and trademark matters, working with outside counsel as needed.
  • Draft, negotiate, and close commercial agreements, including customer master services agreements and statements of work, SaaS and data agreements, reseller and channel arrangements, vendor and technology agreements, nondisclosure agreements, and government subcontracts.
  • Run deals independently from first draft to signature, setting negotiation objectives and timelines aligned with business dates.
  • Contribute to the Deputy General Counsel's template and playbook program by standardizing language and reducing cycle time on routine paper.
  • Explain business risk by clarifying the actual exposure, potential fixes, and what is worth accepting.
  • Serve as the day-to-day legal partner to Sales and Client Success on active deals and renewals by joining customer calls, drafting and negotiating agreements, and achieving signature on the business timeline.
  • Explain AI, data use, privacy, and intellectual property positions to commercial clients and their counsel in plain terms.
  • Build talk tracks, FAQs, and one-pagers that enable Sales and Client Success to answer routine AI and data questions without involving Legal.
  • Provide clear answers about what is standard, negotiable, and requires escalation to prevent deals from stalling.
Desired Qualifications
  • Experience selling into or buying from health plans, and familiarity with payer procurement and security review processes.
  • Exposure to government healthcare contracting, including CMS, state Medicaid, or federal subcontracts, and associated flow-down terms.
  • Experience building contract templates, playbooks, or a deal desk from an unstructured starting point.
  • Familiarity with emerging AI governance frameworks and how they apply in a regulated industry.

About the company

Machinify uses artificial intelligence to optimize decision-making in healthcare. It provides AI-driven applications that improve operational efficiency for health plans, payers, and providers, acting as a central nervous system to manage data-driven decisions. Its products streamline processes like claims processing and utilization management by deploying a growing portfolio of applications on the Machinify platform, designed for fast implementation and immediate ROI. Differences from competitors include an AI-first platform tailored to healthcare administration, a rapid deployment model, and a customer-focused approach that aims to deliver tangible results quickly. The company’s goal is to transform healthcare administration by reclaiming control over healthcare expenditures and improving efficiency and patient outcomes through data-driven decisions.

Company Size

1,001-5,000

Company Stage

Series A

Total Funding

$15.6M

Headquarters

Palo Alto, California

Founded

2016

Get referred to Machinify

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 2026 genetic testing launched with one Medicaid program finding $70 million savings.
  • Machinify now serves over 85 health plans and 270 million lives, per company materials.
  • Performant's October 2025 acquisition expands Machinify into government programs and broader recovery revenue.

What critics are saying

  • Axios reported July 24, 2026 that New Mountain Capital is shopping Machinify.
  • Rawlings, Apixio PI, and Performant integration still tests one brand and one operating model.
  • Audit-heavy payment recovery antagonizes providers, inviting appeals, scrutiny, and slower deployments.

What makes Machinify unique

  • Machinify spans prepayment, postpayment, recovery, and benefits coordination across payers.
  • Its July 2026 genetic-testing engine embeds InformedDNA expertise into payer policy workflows.
  • The October 2025 Performant deal fused AI software with audit-recovery operations and government access.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Medical, dental, & vision
  • Flexible work environment
  • Generous PTO
  • Competitive salary
  • Equity
  • 401(k)
  • Sponsorship
  • Generous L&D Reimbursement policy

Growth & Insights and Company News

6 month growth

6%

1 year growth

16%

2 year growth

27%
IT Digest
Jul 14th, 2026
Machinify adds genetic testing expertise to its comprehensive payment intelligence platform.

Machinify adds genetic testing expertise to its comprehensive payment intelligence platform. Machinify announced a new genetic testing capability, extending the platform's intelligence into one of healthcare's fastest-growing and most clinically complex specialties. The expansion represents another step in applying Machinify's AI to increasingly sophisticated healthcare payment decisions, helping health plans address areas that have outpaced traditional payment integrity approaches. Genetic testing represents one of the fastest-growing and most clinically nuanced areas of healthcare, with more than 150,000 tests on the market today and more than 10 new ones introduced daily. The pace of innovation, combined with evolving evidence, coding structures, payer policies, and coverage requirements, makes the category particularly difficult to manage at scale. The capability builds on Machinify's acquisition of InformedDNA's genetic testing payment integrity business, encoding decades of specialized genetic testing review expertise directly into the Machinify platform. By combining AI with deep clinical expertise, Machinify enables health plans to make more informed decisions throughout the payment lifecycle, whether preventing incorrect payments before they occur or identifying overpayments downstream. "Precision medicine is generating more clinical complexity than any human review organization can keep up with, and genetic testing is the sharp edge of that," said David Pierre, CEO of Machinify. "We didn't build a genetic testing tool. We taught our AI to reason about genetic testing the same way it already reasons about the rest of the claim, with deep human expertise built in. That's the whole idea behind Machinify: as healthcare gets more complex, machine intelligence keeps the lead because every decision makes the next one smarter. That's how we bend the cost curve." The platform applies a specialized genetic testing knowledge base alongside each payer's medical policies to evaluate claims within their full clinical and contractual context. Grounded in Machinify's experience supporting Medicare, Medicaid, and commercial health plans, the models are developed, validated, and continuously governed by the company's board-certified geneticists and clinical experts. Every determination is transparent, defensible, and fully auditable. The approach is already delivering measurable results. In one Medicaid program, the capability identified more than $70 million in savings across reproductive and pharmacogenomic testing while improving the accuracy of payments for these services going forward. "Specialty areas like genetic testing are more important than ever; the science is evolving daily, and the spend has accelerated dramatically," said Tom Magnotta, President of Complex Payment Solutions at Machinify. "We are actively investing in and expanding our content on the platform. Genetic testing is just one of many areas where Machinify is deploying solutions to solve complex challenges for our clients using an AI-first approach." The genetic testing solution is available now to Machinify clients through the platform's real-time pre-payment solution or as a post-payment extension where retrospective recovery is required.

Associated Press
Jul 13th, 2026
Machinify adds genetic testing AI to payment platform, finds $70M in Medicaid savings

Machinify has launched a genetic testing capability on its payment intelligence platform for health plans. The expansion follows the company's acquisition of InformedDNA's genetic testing payment integrity business. The new capability uses AI combined with clinical expertise to help health plans manage payment decisions for genetic testing, one of healthcare's fastest-growing areas with over 150,000 tests currently on the market and more than 10 new ones introduced daily. The platform applies a specialised knowledge base alongside payer medical policies to evaluate claims. In one Medicaid programme, the capability identified over $70 million in savings across reproductive and pharmacogenomic testing. Machinify's platform is deployed by over 85 health plans, including many of the top 20, representing more than 270 million lives.

Dallas Next
Oct 21st, 2025
Dallas-Based Machinify Closes $670M Acquisition of Nasdaq-Listed Performant Healthcare

Dallas-Based Machinify closes $670M acquisition of nasdaq-listed Performant Healthcare. Machinify said that bringing together Performant's deep audit and recovery expertise with Machinify's advanced AI platform will enable the company to deliver faster, more accurate insights, further reduce administrative burden, and unlock greater savings for health plans. Left: Machinify CEO David Pierre; Right: Simeon Kohl, CEO of Performant Healthcare [Photos: LinkedIn/Performant] Dallas-based healthcare intelligence company Machinify has closed its acquisition of Plantation, Florida-based Performant Healthcare (Nasdaq: PHLT) for roughly $670 million. Machinify said the deal expands its AI-powered platform to reach a broader range of clients, including government programs, and accelerates its mission to simplify and modernize healthcare payments. With the acquisition, the New Mountain Capital-backed company closed its second major acquisition in 2025 to expand its AI-powered operating system to a broader range of clients. "We're thrilled to bring Performant into Machinify with such highly complementary assets," Machinify CEO David Pierre said in a statement. "Performant has built deep relationships in the government sector, which expands on Machinify's strong and expanding presence with national and regional payers. Together, we can offer our clients the most complete, data-driven platform for ensuring every healthcare dollar is used effectively." Machinify said that combining Performant's deep audit and recovery expertise with Machinify's advanced AI platform will enable the company to deliver faster, more accurate insights, further reduce administrative burden, and unlock greater savings for health plans. The integration enhances Machinify's ability to serve commercial and government payers with end-to-end intelligence, Machinify added, spanning claim error detection, prevention, recovery, and coordination of benefits. 'Supporting better outcomes' Performant CEO Simeon Kohl will remain with the company, joining the Machinify leadership team. Kohl said the acquisition comes at a key time in the industry. "I'm excited to join forces with Machinify at such a pivotal moment for the industry," Kohl said. "By combining our deep expertise with Machinify's AI platform, we'll be able to deliver even greater value to our clients - streamlining the payment process, improving accuracy, and supporting better outcomes across the healthcare system." "Performant strengthens Machinify's leadership as the next-generation platform for payment accuracy and intelligence," Matt Holt, managing director and president of private equity at New Mountain Capital, said in a statement. "This strategic integration aligns with Machinify's mission to make payments smarter, faster, and more transparent. We're excited about the significant value it will unlock for payers, providers, and the entire healthcare ecosystem." With the addition of Performant, Machinify said it now supports hundreds of millions of claims annually and delivers billions in savings through its unified AI and human-expertise model - helping clients reduce waste, improve provider relationships, and ensure accuracy from contracts to claims. Performant's shares will no longer be publicly traded and will be delisted from Nasdaq, as the company will now operate as a privately held entity. New York-based New Mountain Capital emphasizes business building and growth, rather than excessive risk, as it pursues long-term capital appreciation. The firm currently manages private equity, strategic equity, credit, and net lease real estate funds with more than $55 billion in assets under management. Track Dallas-Fort Worth's business and innovation landscape with its curated news in your inbox Tuesday-Thursday. R E A D N E X T. * AI Tinkerers Now Has a Dallas-Fort Worth Chapter: 'This Is for People Who Are Actually Using AI' Data scientist Anmolika Singh put Dallas on the global AI Tinkerers map. At the first meetup, more than 30 pros - founders to Fortune 500 technologists - showed up to trade ideas, projects, and solutions. * UT Dallas Study Tests AI as a Triage Tool in Breast Cancer Screenings Rather than replace radiologists, UTD researchers say AI could help flag low-risk mammograms for automated review. The approach could cut costs and ease delays as cancer rates rise and the diagnostic workforce shrinks. * With $4M Pre-Seed Funding, North Texas' Humancore Launches 'Multiplayer AI Advisor' Platform Plano-based Humancore describes its Multiplayer platform as an AI advisor that goes beyond traditional coaching and generic prompts by understanding not just the manager, but also their team. * Is Your Organization Ready for AI? Key Considerations to Assess AI Readiness Avoid common pitfalls with practical insights from guiding Fortune 500 companies through AI adoption * Caring for Its Elders, Intelligently: How Technology Can Bring Ease, Connection, and Better Health to Aging Americans Dallas is aging faster than ever, with seniors facing rising challenges of isolation, health, and care. Technology, when designed with empathy, can bridge these gaps - connecting families, empowering caregivers, and enabling prevention. By building tools with empathy, Dallas Next LLC can transform elder care from survival to peace of mind and joy.

Business Wire
Aug 2nd, 2025
Performant Healthcare, Inc. to Be Acquired by Machinify

Performant Healthcare, Inc. (Nasdaq: PHLT) (the “Company” or “Performant”), a leading provider of technology-enabled payment integrity, eligibility, and rela...

PE Hub
Jan 10th, 2025
New Mountain Capital to acquire healthcare tech firm Machinify

New Mountain Capital has agreed to acquire Machinify, a Palo Alto, California-based provider of artificial intelligence-powered software focused on healthcare payments.